Nab-paclitaxel is effective against intrahepatic cholangiocarcinoma via disruption of desmoplastic stroma

Intrahepatic cholangiocarcinoma (IH-CCA) is the second predominant hepatic malignancy worldwide. However, effective treatment strategies for IH-CCA have not yet been developed. Nab-paclitaxel may be an effective drug against IH-CCA, a type of desmoid-like tumor, and its antitumor effects may be attr...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Oncol Lett
Autores principales: Chang, Peter Mu-Hsin, Cheng, Chi-Tung, Wu, Ren-Chin, Chung, Yi-Hsiu, Chiang, Kun-Chun, Yeh, Ta-Sen, Liu, Chun-Yu, Chen, Ming-Han, Chen, Ming-Huang, Yeh, Chun-Nan
Formato: Artigo
Lenguaje:Inglês
Publicado: D.A. Spandidos 2018
Materias:
Articles
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC6019977/
https://ncbi.nlm.nih.gov/pubmed/29963132
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/ol.2018.8690
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares